Access to Transplant
Reduce your patients’ treatment barriers
Your patients should have access to the cellular therapies they need to treat their disease—whether those therapies are transplant or new cell or gene therapies. Our goal is to help you remove your patients’ barriers to treatment and deliver high-quality cell therapy products in the timeline you need them.
ASTCT–NMDP/Be The Match ACCESS Initiative
The ACCESS Initiative is taking aim at patient access and outcomes inequities in transplant and cell therapy. To create meaningful, sustained change, we must have active, sustained engagement from across the transplant and cell therapy ecosystem.
Discover how you can get involved in the ACCESS Initiative and make a difference for patients.
Explore information on patient assistance grants to help remove financial barriers before and after treatment.
Access our free patient support programs, education and resources to help your patients learn about and plan for treatment and recovery.
Find information and tools to help you quickly navigate the reimbursement landscape for transplant.
Learn how the Be The Match Jason Carter Clinical Trials Search & Support program can help you find appropriate clinical trials for your patients.
Discover how Related Donor Services provides solutions to travel, logistical and financial barriers to donation when your patient’s donor is a relative.
Understand how HLA Today can help improve referral timing and outcomes for patients by providing your referring hematologists/oncologists with HLA typing and preliminary donor search results as early as possible after diagnosis.
Explore the initiatives underway to develop a more effective registry for our transplant center partners. Our goal is to recruit younger and more ethnically diverse donors who will be available when you need them.
Discover how our we’re improving our services and working with our transplant center, apheresis center and marrow collection center partners to deliver high-quality products for your patients on your timeline.
Learn how through Be The Match BioTherapies, we’re supporting companies developing and delivering next-generation cell therapies to accelerate patient access to treatment.